U.S. Office REITs Stock News

Dillard’s, Inc. recently introduced Cyd Morris x Gianni Bini, an exclusive, limited-edition capsule collection with designer Cydney Morris, available only in its stores and online. This first-time collaboration expands Dillard’s Gianni Bini label with a cohesive mix of nostalgic, coastal-inspired apparel and accessories tailored to modern lifestyles. We’ll now examine how this exclusive Cyd Morris x Gianni Bini launch, and its emphasis on limited-edition design, shapes Dillard’s investment...

In recent days, Chipotle Mexican Grill received an analyst upgrade to Outperform despite ongoing sales pressures, cautious consumer spending, and intense competition across the restaurant industry. At the same time, management is pressing ahead with plans to open 350 to 370 new restaurants in 2026, underscoring a commitment to expansion even as comparable sales remain under pressure. Now we’ll examine how this analyst upgrade, alongside Chipotle’s aggressive new restaurant expansion,...

If you are wondering whether Southwest Airlines at around US$40.21 is offering value right now, the key question is how that price stacks up against what the business may reasonably be worth. The stock has seen mixed recent returns, with a 6.9% gain over the last 7 days, a 6.1% decline over 30 days and a 2.6% decline year to date, while the 1 year return sits at 59.1% and the 3 year return at 33.3% compared with a 31.0% decline over 5 years. Recent headlines have focused on Southwest...

Cogent Biosciences recently completed and submitted a New Drug Application to the FDA for bezuclastinib in previously imatinib-treated GIST, supported by Phase 3 PEAK data showing improved progression-free survival and response rates versus sunitinib alone, and the filing is being reviewed under the Real-Time Oncology Review program with Breakthrough Therapy Designation. Alongside this, growing use of expanded access programs and interest from high-profile investors highlight how...

FormFactor (NasdaqGS:FORM) is set to gain from the easing of U.S. Iran tensions and the reopening of the Strait of Hormuz. This development restores key semiconductor supply routes that had been disrupted during the recent conflict. Critical materials for chipmaking are now moving more freely through the Strait, reducing logistical strain on suppliers and customers. The change is particularly relevant for FormFactor, given its role in advanced testing and measurement for semiconductor...

Investors may be wondering if Viking Therapeutics at around US$34.95 is still a sensible entry or hold after a strong run, or if the price is starting to run ahead of the story. The stock shows mixed recent performance, with returns of 0.4% over 7 days, 0.8% over 30 days, a 1.3% decline year to date, and a 62.4% gain over the last year, while the 3 year return is 87.7% and the 5 year return is very large. Recent headlines have focused on Viking Therapeutics as part of broader discussions...

Why Figma stock is suddenly in focus Figma (FIG) has drawn fresh attention after its share price hit new lows, as investors react to concerns about generative AI competition, pressure from established rivals, and sizeable stock sales by early backers. See our latest analysis for Figma. Those worries are hitting the share price hard, with a 1 day share price return of 5.31% decline, adding to a 30 day share price return of 32.70% decline and a year to date share price return of 49.27% decline,...

In early April 2026, Super Group (SGHC) came under pressure after a bearish report from Spruce Point Capital Management and lowered 2026 revenue forecasts tied to UK tax changes and sports-betting volatility. Despite announcing a special dividend and an increased regular payout, cautious insider activity and questions around intrinsic valuation have raised concerns among some observers about the balance of risk and reward. Next, we’ll examine how the bearish Spruce Point report and trimmed...

Halozyme Therapeutics (NasdaqGS:HALO) announced a global exclusive collaboration and license agreement with Vertex Pharmaceuticals for its Hypercon technology. The agreement allows Vertex to use Hypercon for up to three drug targets, with Halozyme eligible for upfront payments, potential milestones, and royalties. The deal broadens Halozyme’s technology portfolio beyond its existing ENHANZE franchise into an additional platform offering. Halozyme Therapeutics focuses on drug delivery...

In the past week, Hewlett Packard Enterprise reported a strong first quarter with double-digit revenue growth and earnings ahead of expectations, while also raising its outlook for Networking and full-year free cash flow. Alongside this, HPE’s evolving AI and networking ecosystem, from updated UALink specifications to new Wi-Fi patent licenses and AI partnerships, highlights how the company is positioning its infrastructure for emerging workloads and enterprise needs. Next, we’ll examine how...

The Buckle, Inc. reported that for the 5-week period ended April 4, 2026, comparable store net sales rose 7.0% and total net sales increased 8.2% to US$118.0 million, with year-to-date net sales for the 9-week period up 8.5% to US$202.5 million versus the prior year. Alongside these stronger sales trends, Buckle elevated long-time executive Scott A. Werth to Senior Vice President of Stores, placing its more than 7,000-person sales team under experienced, internally developed leadership...

Why Omnicom Group is Back on Investors’ Radar Omnicom Group (OMC) is drawing investor attention after recent share price swings, with the stock showing mixed returns over the past year and contrasting signals from its latest revenue, profit figures, and valuation metrics. See our latest analysis for Omnicom Group. The recent share price pullback, with a 1 month share price return of a 7.53% decline and a year to date share price return of a 7.92% decline, contrasts with a 1 year total...

If you are wondering whether FuboTV's share price lines up with its underlying worth, this breakdown will help you frame that question in a clear and practical way. The stock last closed at US$12.04, with a recent 7 day return of 23.2%, a 30 day return of 14.2%, a year to date return of 61.3%, a 1 year return of 63.6%, and a 5 year return of 94.8%. These mixed returns have kept FuboTV on the radar of investors who want to understand whether recent price action reflects changing expectations...

SM Energy (SM) recently completed a cash tender offer for up to US$1b of 8.375% senior notes due 2028, drawing fresh attention to the stock just as sentiment around oil and its earnings outlook shifts. See our latest analysis for SM Energy. Those tender offer results come at a time when SM Energy's share price has pulled back 1.7% on the day and 7.5% over the past week, but still shows a 59.3% 3 month share price return and a 77.8% 5 year total shareholder return. This suggests that long term...

If you have been wondering whether Marsh & McLennan Companies at around US$173 a share is a fair deal or not, this article walks through what the current price might be implying about value. The stock has slipped around 0.8% over the last week, 0.5% over the last month and 5.1% year to date, with a 22.9% decline over the past year contrasted against 5.4% and 47.1% returns over the past 3 and 5 years. Recent news around Marsh & McLennan Companies has focused on the business as a major...

PDD Holdings’ Q4 2025 results, released in late March, showed earnings per share of 17.69 and revenue of CN¥123.91 billion, both below analyst expectations, amid pressure from competition, economic softness, and heavy supply chain investments. At the same time, the group is confronting heightened regulatory scrutiny in China and abroad, including investigations and potential changes to import duty rules that could affect its Temu platform and broader operations. We’ll now examine how this...

Revenue beat and growth outlook put Standex International (SXI) in focus Standex International (SXI) is on investors’ radar after reporting a 16.6% year-on-year revenue increase that topped analyst expectations, coupled with guidance pointing to mid to high single digit organic growth. See our latest analysis for Standex International. Alongside the guidance update, the share price has climbed 14.92% over the past 90 days and the 1-year total shareholder return is 97.44%. This indicates that...

McDonald’s (NYSE:MCD) has launched its McValue 2.0 menu across the US, featuring an Under $3 Menu and new bundled meal deals. The company is pairing these offers with fresh pop culture collaborations, including KPop Demon Hunters themed meals. McDonald’s has also appointed new senior executives to strengthen its leadership team as affordability pressures remain in focus. For you as an investor, McDonald’s sits at the intersection of quick service dining, branding, and real estate, where...

Atlassian (NasdaqGS:TEAM) has launched new AI capabilities in Confluence, including an open beta of Remix, a tool that turns static text into visual stories. The company has also introduced pre-built third party agents that connect Confluence with partner apps such as Lovable, Replit, and Gamma for automatic content transformation and workflow integration. For Atlassian, known for collaboration products like Confluence and Jira, this move pushes its core knowledge product toward a more...

Recent performance snapshot for Stewart Information Services With no single headline event driving attention, Stewart Information Services (STC) has attracted interest based on its recent share performance, including a 1.2% gain over the past day and 7.8% over the past week. See our latest analysis for Stewart Information Services. That recent upswing comes after a softer patch, with the share price showing a 4.9% decline over three months and a 6.8% decline year to date, while longer term...

Harmony Biosciences Holdings (HRMY) is in focus after appointing Peter Anastasiou as Chief Operating Officer, adding Troy Ignelzi to the Board, and nominating Geno J. Germano for election at the 2026 shareholder meeting. See our latest analysis for Harmony Biosciences Holdings. The recent leadership reshuffle comes as Harmony Biosciences trades at US$29.16, with a 7 day share price return of 5.12% contrasting with a 90 day share price decline of 24.36% and a relatively flat 1 year total...

In early April 2026, semiconductor materials supplier Entegris benefited as the de-escalation of the U.S.-Iran conflict reopened the Strait of Hormuz, a key route for noble gases and other inputs used in chip fabrication. This development directly reinforces Entegris’ role in securing critical materials integrity for advanced semiconductor manufacturing, at a time when hedge fund interest highlights its importance in the supply chain. We’ll now examine how restored access to critical...

In late March 2026, a Chicago jury ordered Abbott Laboratories to pay US$53 million in compensatory damages to families alleging the company failed to adequately warn that its cow’s milk-based formula for premature infants could cause necrotizing enterocolitis, a potentially deadly bowel disease. This verdict, with punitive damages still to be determined, raises fresh questions about Abbott’s legal exposure, brand perception in infant nutrition, and the potential long-term impact on its...

Eli Lilly's oral GLP-1 obesity pill Foundayo is beginning a broad U.S. launch via Amazon Pharmacy, GoodRx, Ro, Weight Watchers, and LillyDirect. The rollout uses multiple direct-to-consumer and digital health channels, with a focus on home delivery, self-pay options, and integrated clinical support. The move is intended to expand access to oral GLP-1 treatments and could influence how patients obtain and manage obesity therapies. Eli Lilly, traded as NYSE:LLY, is positioning Foundayo as a...